MONDAY, March 29, 2021 (HealthDay News) — Middle-aged adults looking to boost their muscle mass do not need to bulk up on protein, a new study suggests. Researchers found that 10 weeks of strength training plus a moderate amount of protein were enough to build muscle in previously sedentary middle-agedContinue Reading

MONDAY, March 29, 2021 (HealthDay News) — Middle-aged folks who feel persistently lonely appear to have a nearly doubled risk of developing dementia or Alzheimer’s disease, a new study reports. If you take steps to counter your loneliness, however, you might actually reduce your dementia risk, the researchers found. DementiaContinue Reading

THURSDAY, March 25, 2021 (HealthDay News) — Medicine may have advanced by leaps and bounds over the last century, but Generation X and millennials are in worse health than their parents and grandparents were at their age. That’s the conclusion of a new study that looked at markers of physicalContinue Reading

TUESDAY, March 23, 2021 (HealthDay News) — Among older Americans, deaths from falls are up sharply, dovetailing with a surge in use of medications that increase the risk of falling, researchers say. Two decades ago, about 57% of U.S. seniors took medications that increased their risk of falls. By 2017,Continue Reading

THURSDAY, March 18, 2021 (HealthDay News) — Nearly one-third of seniors who take thyroid hormone also take drugs known to interfere with tests of thyroid function, a new study finds. It’s common for older adults to take a thyroid hormone (levothyroxine) to treat low levels of natural thyroid hormone. ButContinue Reading

WEDNESDAY, March 17, 2021 (HealthDay News) — Serious vision problems among older Americans have declined sharply, and the improvement has been greatest among women, folks over 85 and seniors who are Black or Hispanic, a nationwide study shows. “The implications of a reduction in vision impairment are significant,” said studyContinue Reading

SATURDAY, March 13, 2021 (HealthDay News) — About 7 out of 10 Alzheimer’s patients wound up free of the brain plaques that are a hallmark of the disease after treatment with a potentially breakthrough experimental drug, clinical trial results show. The drug, donanemab, also significantly slowed the patients’ brain decline,Continue Reading